Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 105

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Disruption of drug-resistant biofilms using de novo designed short α-helical antimicrobial peptides with idealized facial amphiphilicity

Khara, Jasmeet Singh, Obuobi, Sybil, Wang, Ying, Hamilton, Melissa Shea, Robertson, Brian D., Newton, Sandra M., Yang, Yi Yan, Langford, Paul R., Ee, Pui Lai Rachel · 2017 · Acta Biomaterialia

Abstract

The escalating threat of antimicrobial resistance has increased pressure to develop novel therapeutic strategies to tackle drug-resistant infections. Antimicrobial peptides have emerged as a promising class of therapeutics for various systemic and topical clinical applications. In this study, the de novo design of α-helical peptides with idealized facial amphiphilicities, based on an understanding of the pertinent features of protein secondary structures, is presented. Synthetic amphiphiles composed of the backbone sequence (X1Y1Y2X2)n, where X1 and X2 are hydrophobic residues (Leu or Ile or Trp), Y1 and Y2 are cationic residues (Lys), and n is the number repeat units (2 or 2.5 or 3), demonstrated potent broad-spectrum antimicrobial activities against clinical isolates of drug-susceptible and multi-drug resistant bacteria. Live-cell imaging revealed that the most selective peptide, (LKKL)3, promoted rapid permeabilization of bacterial membranes. Importantly, (LKKL)3 not only suppressed biofilm growth, but effectively disrupted mature biofilms after only 2 h of treatment. The peptides (LKKL)3 and (WKKW)3 suppressed the production of LPS-induced pro-inflammatory mediators to levels of unstimulated controls at low micromolar concentrations. Thus, the rational design strategies proposed herein can be implemented to develop potent, selective and multifunctional α-helical peptides to eradicate drug-resistant biofilm-associated infections. Antimicrobial peptides (AMPs) are increasingly explored as therapeutics for drug-resistant and biofilm-related infections to help expand the size and quality of the current antibiotic pipeline in the face of mounting antimicrobial resistance. Here, synthetic peptides rationally designed based upon principles governing the folding of natural α-helical AMPs, comprising the backbone sequence (X1Y1Y2X2)n, and which assemble into α-helical structures with idealized facial amphiphilicity, is presented. These multifunctional peptide amphiphiles demonstrate high bacterial selectivity, promote the disruption of pre-formed drug-resistant biofilms, and effectively neutralize endotoxins at low micromolar concentrations. Overall, the design strategies presented here could provide a useful tool for developing therapeutic peptides with broad-ranging clinical applications from the treatment and prevention of drug-resistant biofilms to the neutralization of bacterial endotoxins.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.actbio.2017.04.032

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 40

  1. Liu, 2016, Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study, Lancet Infect. Dis., 16, 161, 10.1016/S1473-3099(15)00424-7 · DOI · Paper page
  2. Hall-Stoodley, 2004, Bacterial biofilms: from the natural environment to infectious diseases, Nat. Rev. Microbiol., 2, 95, 10.1038/nrmicro821 · DOI · Paper page
  3. de la Fuente-Núñez, 2013, Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies, Curr. Opin. Microbiol., 16, 580, 10.1016/j.mib.2013.06.013 · DOI · Paper page
  4. Hancock, 1998, Cationic peptides: a new source of antibiotics, Trends Biotechnol., 16, 82, 10.1016/S0167-7799(97)01156-6 · DOI · Paper page
  5. Zasloff, 2002, Antimicrobial peptides of multicellular organisms, Nature, 415, 389, 10.1038/415389a · DOI · Paper page
  6. Hilchie, 2013, Immune modulation by multifaceted cationic host defense (antimicrobial) peptides, Nat. Chem. Biol., 9, 761, 10.1038/nchembio.1393 · DOI · Paper page
  7. Wiradharma, 2013, Rationally designed α-helical broad-spectrum antimicrobial peptides with idealized facial amphiphilicity, Macromol. Rapid Commun., 34, 74, 10.1002/marc.201200534 · DOI
  8. Jacob, 2013, Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity, J. Pept. Sci., 19, 700, 10.1002/psc.2552 · DOI
  9. Wang, 2012, Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins, Biochemistry, 51, 653, 10.1021/bi2016266 · DOI
  10. Deslouches, 2005, De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity, Antimicrob. Agents Chemother., 49, 316, 10.1128/AAC.49.1.316-322.2005 · DOI · Paper page
  11. Ong, 2014, Strategies employed in the design and optimization of synthetic antimicrobial peptide amphiphiles with enhanced therapeutic potentials, Adv. Drug Delivery Rev., 78, 28, 10.1016/j.addr.2014.10.013 · DOI · Paper page
  12. Bell, 2003, Arming the enemy: the evolution of resistance to self-proteins, Microbiology, 149, 1367, 10.1099/mic.0.26265-0 · DOI
  13. Hill, 2000, De novo design of helical bundles as models for understanding protein folding and function, Acc. Chem. Res., 33, 745, 10.1021/ar970004h · DOI · Paper page
  14. Khara, 2014, Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin, Biomaterials, 35, 2032, 10.1016/j.biomaterials.2013.11.035 · doi:10.1016/j.biomaterials.2013.11.035
  15. Khara, 2015, Designing α-helical peptides with enhanced synergism and selectivity against Mycobacterium smegmatis: discerning the role of hydrophobicity and helicity, Acta Biomater., 28, 99, 10.1016/j.actbio.2015.09.015 · doi:10.1016/j.actbio.2015.09.015
  16. Wiradharma, 2011, Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents, Biomaterials, 32, 2204, 10.1016/j.biomaterials.2010.11.054 · DOI · Paper page
  17. Pauling, 1951, The structure of proteins: two hydrogen-bonded helical configurations of the polypeptide chain, Proc. Natl. Acad. Sci. U.S.A., 37, 205, 10.1073/pnas.37.4.205 · DOI · Paper page
  18. Eisenberg, 1984, The hydrophobic moment detects periodicity in protein hydrophobicity, Proc. Natl. Acad. Sci. U.S.A., 81, 140, 10.1073/pnas.81.1.140 · DOI · Paper page
  19. DeGrado, 1985, Induction of peptide conformation at apolar water interfaces. 1. A study with model peptides of defined hydrophobic periodicity, J. Am. Chem. Soc., 107, 7684, 10.1021/ja00311a076 · DOI · Paper page
  20. O'Neil, 1990, A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids, Science, 250, 646, 10.1126/science.2237415 · DOI · Paper page
  21. Xiong, 1995, Periodicity of polar and nonpolar amino acids is the major determinant of secondary structure in self-assembling oligomeric peptides, Proc. Natl. Acad. Sci. U.S.A., 92, 6349, 10.1073/pnas.92.14.6349 · DOI · Paper page
  22. Khara, 2016, Unnatural amino acid analogues of membrane-active helical peptides with anti-mycobacterial activity and improved stability, J. Antimicrob. Chemother., 71, 2181, 10.1093/jac/dkw107 · DOI
  23. Haney, 2015, High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides, Peptides, 71, 276, 10.1016/j.peptides.2015.03.015 · DOI
  24. Segev-Zarko, 2015, Mechanisms of biofilm inhibition and degradation by antimicrobial peptides, Biochem. J., 468, 259, 10.1042/BJ20141251 · DOI
  25. Karsi, 2006, Development of bioluminescent Edwardsiella ictaluri for noninvasive disease monitoring, FEMS Microbiol. Lett., 260, 216, 10.1111/j.1574-6968.2006.00310.x · DOI
  26. Ong, 2013, Short synthetic β-sheet forming peptide amphiphiles as broad spectrum antimicrobials with antibiofilm and endotoxin neutralizing capabilities, Adv. Funct. Mater., 23, 3682, 10.1002/adfm.201202850 · DOI
  27. Yau, 1998, The preference of tryptophan for membrane interfaces, Biochemistry, 37, 14713, 10.1021/bi980809c · DOI · Paper page
  28. Hu, 2011, Designed antimicrobial and antitumor peptides with high selectivity, Biomacromolecules, 12, 3839, 10.1021/bm201098j · DOI
  29. Nguyen, 2010, Serum stabilities of short tryptophan-and arginine-rich antimicrobial peptide analogs, PLoS ONE, 5, e12684, 10.1371/journal.pone.0012684 · DOI · Paper page
  30. Deslouches, 2013, Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens, Antimicrob. Agents Chemother., 57, 2511, 10.1128/AAC.02218-12 · DOI · Paper page
  31. Wieprecht, 1999, Thermodynamics of the α-helix-coil transition of amphipathic peptides in a membrane environment: implications for the peptide-membrane binding equilibrium, J. Mol. Biol., 294, 785, 10.1006/jmbi.1999.3268 · DOI · Paper page
  32. Blondelle, 1992, Design of model amphipathic peptides having potent antimicrobial activities, Biochemistry, 31, 12688, 10.1021/bi00165a020 · DOI · Paper page
  33. Andrushchenko, 2007, Interactions of tryptophan-rich cathelicidin antimicrobial peptides with model membranes studied by differential scanning calorimetry, Biochim. Biophys. Acta, 1768, 2447, 10.1016/j.bbamem.2007.05.015 · DOI
  34. Hancock, 2006, Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies, Nat. Biotechnol., 24, 1551, 10.1038/nbt1267 · DOI · Paper page
  35. Hancock, 2002, Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics, Curr. Drug Targets Infect. Disord., 2, 79, 10.2174/1568005024605855 · DOI · Paper page
  36. Costerton, 1999, Bacterial biofilms: a common cause of persistent infections, Science, 284, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
  37. Cobb, 1996, Nitric oxide and septic shock, JAMA, 275, 1192, 10.1001/jama.1996.03530390058035 · DOI
  38. Scott, 2000, Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein, J. Immunol., 164, 549, 10.4049/jimmunol.164.2.549 · DOI · Paper page
  39. Mookherjee, 2006, Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide, J. Leukocyte Biol., 80, 1563, 10.1189/jlb.0106048 · DOI
  40. Néron, 2009, Mobyle: a new full web bioinformatics framework, Bioinformatics, 25, 3005, 10.1093/bioinformatics/btp493 · DOI · Paper page

Cited by

Metadata

Authors
Khara, J. S., Obuobi, S., Wang, Y., Hamilton, M. S., Robertson, B. D., Newton, S. M., Yang, Y. Y., Langford, P. R., & Ee, P. L. R.
Venue
Acta Biomaterialia
Publisher
Elsevier BV
Published
2017-07
Volume
57
Pages
103-114
ISSN
1742-7061
Cited by
105
References
1
Language
en
Licence
Funders
  • Singapore Ministry of Health’s National Medical Research Council (NMRC/1298/2011, NMRC/OFIRG/0026/2016)
  • British Society of Antimicrobial Chemotherapy
  • Imperial College London Biomedical Research Centre
  • Institute of Bioengineering and Nanotechnology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.